Market OverviewThe Global Generic Drugs Market was valued at $411.99 Billion in 2022 and is projected to reach $613.34 ...

Public anger in China over concerns raised by doctors that generic drugs used in public hospitals are increasingly ...

Axsome Therapeutics, Inc. (NASDAQ:AXSM) signed a settlement agreement with Teva Pharmaceuticals Inc (NYSE:TEVA). The ...

China’s drug procurement system is under scrutiny as doctors raise alarms over the effectiveness of generic medicines used in ...

China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed ...

The breakthrough in drug delivery hinges on the development of nanoarchaeosomes, which are nanoparticles loaded with ...

Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy ...

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Public discontent is brewing in China due to the growing ineffectiveness of generic drugs used in state hospitals, BBC ...

Global pharma company Jazz Pharmaceuticals has ended patent claims related to its cannabinoid-based epilepsy drug, Epidiolex.

Chinese authorities defended the quality of homegrown generic medicines after groups of doctors complained of their efficacy ...